|
Neoplasia
Citations 331-340 of 4217 total displayed.
|
Past content
(since Jan 1997):
|
BMS-214662 potently induces apoptosis of chronic myeloid leukemia stem and progenitor cells and synergizes with tyrosine kinase inhibitors
- Mhairi Copland, Francesca Pellicano, Linda Richmond, Elaine K. Allan, Ashley Hamilton, Francis Y. Lee, Roberto Weinmann, and Tessa L. Holyoake
Blood 2008; 111: 2843-2853.
[Abstract]
[Full text]
[PDF]
Aurora kinase inhibitory VX-680 increases Bax/Bcl-2 ratio and induces apoptosis in Aurora-A-high acute myeloid leukemia
- Xue-Fei Huang, Shao-Kai Luo, Jie Xu, Juan Li, Duo-Rong Xu, Li-Hui Wang, Min Yan, Xian-Ren Wang, Xiang-Bo Wan, Fei-Meng Zheng, Yi-Xin Zeng, and Quentin Liu
Blood 2008; 111: 2854-2865.
[Abstract]
[Full text]
[PDF]
Abolition of stress-induced protein synthesis sensitizes leukemia cells to anthracycline-induced death
- Gro Gausdal, Bjørn Tore Gjertsen, Emmet McCormack, Petra Van Damme, Randi Hovland, Camilla Krakstad, Øystein Bruserud, Kris Gevaert, Joël Vandekerckhove, and Stein Ove Døskeland
Blood 2008; 111: 2866-2877.
[Abstract]
[Full text]
[PDF]
Development of Notch-dependent T-cell leukemia by deregulated Rap1 signaling
- Shu-Fang Wang, Misayo Aoki, Yasuhiro Nakashima, Yoriko Shinozuka, Hiroki Tanaka, Masafumi Taniwaki, Masakazu Hattori, and Nagahiro Minato
Blood 2008; 111: 2878-2886.
[Abstract]
[Full text]
[PDF]
Chromatin modifications induced by PML-RAR repress critical targets in leukemogenesis as analyzed by ChIP-Chip
- Claudia Hoemme, Abdul Peerzada, Gerhard Behre, Yipeng Wang, Michael McClelland, Kay Nieselt, Matthias Zschunke, Christine Disselhoff, Shuchi Agrawal, Fabienne Isken, Nicola Tidow, Wolfgang E. Berdel, Hubert Serve, and Carsten Müller-Tidow
Blood 2008; 111: 2887-2895.
[Abstract]
[Full text]
[PDF]
Complete molecular response of e6a2 BCR-ABL–positive acute myeloid leukemia to imatinib then dasatinib
- David S. Ritchie, Michelle McBean, David A Westerman, Sergey Kovalenko, John F. Seymour, and Alexander Dobrovic
Blood 2008; 111: 2896-2898.
[Abstract]
[Full text]
[PDF]
Intact apoptosis signaling in myeloid leukemia cells determines treatment outcome in childhood AML
- Lüder H. Meyer, Manon Queudeville, Sarah M. Eckhoff, Ursula Creutzig, Dirk Reinhardt, Leonid Karawajew, Wolf-Dieter Ludwig, Karsten Stahnke, and Klaus-Michael Debatin
Blood 2008; 111: 2899-2903.
[Abstract]
[Full text]
[PDF]
BCR-ABL1 mediates up-regulation of Fyn in chronic myelogenous leukemia
- Kechen Ban, Yin Gao, Hesham M. Amin, Adrienne Howard, Claudia Miller, Quan Lin, Xiaohong Leng, Mark Munsell, Menashe Bar-Eli, Ralph B. Arlinghaus, and Joya Chandra
Blood 2008; 111: 2904-2908.
[Abstract]
[Full text]
[PDF]
Single autologous stem-cell transplantation followed by maintenance therapy with thalidomide is superior to double autologous transplantation in multiple myeloma: results of a multicenter randomized clinical trial
- Abderrahman Abdelkefi, Saloua Ladeb, Lamia Torjman, Tarek Ben Othman, Amel Lakhal, Neila Ben Romdhane, Halima El Omri, Moez Elloumi, Hatem Belaaj, Ramzi Jeddi, Lamia Aissaouï, Habib Ksouri, Assia Ben Hassen, Fahmi Msadek, Ali Saad, Mohamed Hsaïri, Kamel Boukef, Ahlem Amouri, Hechmi Louzir, Koussay Dellagi, and Abdeladhim Ben Abdeladhim, on behalf of the Tunisian Multiple Myeloma Study Group
Blood 2008; 111: 1805-1810.
[Abstract]
[Full text]
[PDF]
Aberrant V(D)J recombination is not required for rapid development of H2ax/p53-deficient thymic lymphomas with clonal translocations
- Craig H. Bassing, Sheila Ranganath, Mike Murphy, Velibor Savic, Meagan Gleason, and Frederick W. Alt
Blood 2008; 111: 2163-2169.
[Abstract]
[Full text]
[PDF]
|
|
